title: [Improvement of idiopathic Raynaud's phenomenon following local infusion of botulinum toxin].
authors.affiliation: Service de dermatologie, CHU de Brest, 5, avenue Foch, 29609 Brest cedex, France. Electronic address: anne-marie.roguedas-contios@chu-brest.fr.
authors.forename: A-M
authors.initials: AM
authors.lastname: Roguedas
authors.affiliation: Service de dermatologie, CHU de Brest, 5, avenue Foch, 29609 Brest cedex, France.
authors.forename: L
authors.initials: L
authors.lastname: Misery
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006945:Hyperhidrosis / Q000150:complications / Q000188:drug therapy; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007279:Injections, Subcutaneous; D011928:Raynaud Disease / Q000150:complications / Q000188:drug therapy*; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology
chemical_list: D065087:Acetylcholine Release Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D019274:Botulinum Toxins, Type A; C545476:incobotulinumtoxinA